Fenextra 400 mg ibuprofen

Fenextra is a pharmaceutical brand specializing in ibuprofen-based medications, primarily used as an analgesic, anti-inflammatory, and antipyretic. The product shown, 'Fenextra 400 mg film-coated tablets', is a common treatment for pain and inflammation in the Italian market.

The brand was developed and is owned by FB Health S.r.l., an Italian pharmaceutical company founded in 2011 that focuses on areas such as neurology, psychiatry, and pain management. In 2017, FB Health was acquired by the Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders. Manufacturing primarily takes place in Italy to supply the local market and European subsidiaries, adhering to European pharmaceutical regulatory standards.